Pascal Juillerat
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Perrig K, Krupka N, Jordi S, Rossel J, Biedermann L, Greuter T, Schreiner P, Vavricka S, Juillerat P, Burri E, Zimmermann D, Maillard M, Sulz M, Brand S, Rogler G, Misselwitz B. Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland. Therap Adv Gastroenterol 2022; 15:17562848221074188.
09.02.2022Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
09.02.2022Therap Adv Gastroenterol 2022; 15:17562848221074188
Perrig Kathrin, Krupka Niklas, Jordi Sebastian Bruno Ulrich, Rossel Jean-Benoit, Biedermann Luc, Greuter Thomas, Schreiner Philipp, Vavricka Stephan R, Juillerat Pascal, Burri Emanuel, Zimmermann Dorothee, Maillard Michel H, Sulz Michael Christian, Brand Stephan, Rogler Gerhard, Misselwitz Benjamin
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus E, Ostad-Saffari E, Scalori A, Oh Y, Tole S, Chai A, Pulley J, Lacey S, Sandborn W, HICKORY Study Group. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021; 7:128-140.
17.11.2021Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
17.11.2021Lancet Gastroenterol Hepatol 2021; 7:128-140
Peyrin-Biroulet Laurent, Hart Ailsa, Bossuyt Peter, Long Millie, Allez Matthieu, Juillerat Pascal, Armuzzi Alessandro, Loftus Edward V, Ostad-Saffari Elham, Scalori Astrid, Oh Young S, Tole Swati, Chai Akiko, Pulley Jennifer, Lacey Stuart, Sandborn William J, HICKORY Study Group
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
Schoepfer A, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon H, Straumann A, Safroneeva E, Godat S. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc 2021; 94:912-919.e2.
15.05.2021Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
15.05.2021Gastrointest Endosc 2021; 94:912-919.e2
Schoepfer Alain M, Henchoz Sarah, Biedermann Luc, Schreiner Philipp, Greuter Thomas, Reinhard Antoine, Senn Jonduri, Franke Annett, Burri Emanuel, Juillerat Pascal, Simon Hans-Uwe, Straumann Alex, Safroneeva Ekaterina, Godat Sébastien
A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.
Ruiz F, Wyss A, Rossel J, Sulz M, Brand S, Moncsek A, Mertens J, Roth R, Clottu A, Burri E, Juillerat P, Biedermann L, Greuter T, Rogler G, Pot C, Misselwitz B, Swiss IBD Cohort Study Group. A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br J Pharmacol 2021; 178:3157-3175.
10.03.2021A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.
10.03.2021Br J Pharmacol 2021; 178:3157-3175
Ruiz Florian, Wyss Annika, Rossel Jean-Benoit, Sulz Michael Christian, Brand Stephan, Moncsek Anja, Mertens Joachim C, Roth René, Clottu Aurélie S, Burri Emanuel, Juillerat Pascal, Biedermann Luc, Greuter Thomas, Rogler Gerhard, Pot Caroline, Misselwitz Benjamin, Swiss IBD Cohort Study Group
Fatigue in inflammatory bowel disease and its impact on daily activities
Schreiner P, Misselwitz B, von Känel R, Rogler G, Juillerat P, Pittet V, Vavricka S, Scharl M, Greuter T, Baumann C, Valko P, Biedermann L, Rossel J, Swiss IBD Cohort Study Group. Fatigue in inflammatory bowel disease and its impact on daily activities. Aliment Pharmacol Ther 2020; 53:138-149.
07.11.2020Fatigue in inflammatory bowel disease and its impact on daily activities
07.11.2020Aliment Pharmacol Ther 2020; 53:138-149
Schreiner Philipp, Misselwitz Benjamin, von Känel Roland, Rogler Gerhard, Juillerat Pascal, Pittet Valérie, Vavricka Stephan R, Scharl Michael, Greuter Thomas, Baumann Christian R, Valko Philipp O, Biedermann Luc, Rossel Jean-Benoit, Swiss IBD Cohort Study Group
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update
Vulliemoz M, Brand S, Juillerat P, Mottet C, Ben-Horin S, Michetti P, on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update. Digestion 2020; 101 Suppl 1:16-26.
31.07.2020TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update
31.07.2020Digestion 2020; 101 Suppl 1:16-26
Vulliemoz Marianne, Brand Stephan, Juillerat Pascal, Mottet Christian, Ben-Horin Shomron, Michetti Pierre, on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
Schreiner P, Rogler G, Juillerat P, Vavricka S, Vulliemoz M, Restellini S, Schoepfer A, Michetti P, Brand S, Maillard M, Fehr J, Mueller N, Biedermann L. Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know. J Crohns Colitis 2020
27.06.2020Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
27.06.2020J Crohns Colitis 2020
Schreiner Philipp, Rogler Gerhard, Juillerat Pascal, Vavricka Stephan R, Vulliemoz Marianne, Restellini Sophie, Schoepfer Alain, Michetti Pierre, Brand Stephan, Maillard Michel H, Fehr Jan, Mueller Nicolas J, Biedermann Luc
Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
Misselwitz B, Juillerat P, Sulz M, Siegmund B, Brand S, Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More. Digestion 2020; 101 Suppl 1:69-82.
22.06.2020Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
22.06.2020Digestion 2020; 101 Suppl 1:69-82
Misselwitz Benjamin, Juillerat Pascal, Sulz Michael, Siegmund Britta, Brand Stephan, Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
Yilmaz B, Stelling J, Wiest R, Swiss IBD Cohort Investigators, Rogler G, Maillard M, Pittet V, Geuking M, Mueller C, Michetti P, Fournier N, Franc Y, Bravo F, Ramon C, Øyås O, Juillerat P, Macpherson A. Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease. Nat Med 2019; 25:701.
01.04.2019Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
01.04.2019Nat Med 2019; 25:701
Yilmaz Bahtiyar, Stelling Jörg, Wiest Reiner, Swiss IBD Cohort Investigators, Rogler Gerhard, Maillard Michel H, Pittet Valerie E H, Geuking Markus, Mueller Christoph, Michetti Pierre, Fournier Nicolas, Franc Yannick, Bravo Francisco Damian, Ramon Charlotte, Øyås Ove, Juillerat Pascal, Macpherson Andrew J
Microbial network disturbances in relapsing refractory Crohn's disease
Yilmaz B, Stelling J, Wiest R, Swiss IBD Cohort Investigators, Rogler G, Maillard M, Pittet V, Geuking M, Mueller C, Michetti P, Fournier N, Franc Y, Bravo F, Ramon C, Øyås O, Juillerat P, Macpherson A. Microbial network disturbances in relapsing refractory Crohn's disease. Nat Med 2019; 25:323-336.
21.01.2019Microbial network disturbances in relapsing refractory Crohn's disease
21.01.2019Nat Med 2019; 25:323-336
Yilmaz Bahtiyar, Stelling Jörg, Wiest Reiner, Swiss IBD Cohort Investigators, Rogler Gerhard, Maillard Michel H, Pittet Valerie E H, Geuking Markus, Mueller Christoph, Michetti Pierre, Fournier Nicolas, Franc Yannick, Bravo Francisco Damian, Ramon Charlotte, Øyås Ove, Juillerat Pascal, Macpherson Andrew J
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Vavricka S, Misselwitz B, Scharl M, Heinrich H, Manser C, Safroneeva E, Raja Ali R, Rogler G, Schoepfer A, Greuter T, Zeitz J, Biedermann L, Juillerat P, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflamm Bowel Dis 2017
27.04.2017Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
27.04.2017Inflamm Bowel Dis 2017
Vavricka Stephan R, Misselwitz Benjamin, Scharl Michael, Heinrich Henriette, Manser Christine N, Safroneeva Ekaterina, Raja Ali Raja Affendi, Rogler Gerhard, Schoepfer Alain M, Greuter Thomas, Zeitz Jonas, Biedermann Luc, Juillerat Pascal, Gubler Martin, Gantenbein Claudine, Spoerri Muriel, Froehlich Florian, Seibold Frank, Protic Marijana, Michetti Pierre, Straumann Alex, Fournier Nicolas